Maha Saber Ayad (Maha Saber-Ayad, Maha M Saber, Maha M Saber-Ayad)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 31

Top Topics

Body Mass Index

Breast Cancer Cells

Coronavirus Disease

Top Venues

NPJ precision oncology

International journal of molecular sciences

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Charlotte Steenblock, Maha Saber Ayad, Stefan R Bornstein
International Roadshow: New Advances in Endocrinology and Metabolic Diseases. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 56 (4) (2024)
Jalal Taneera, Anila Khalique, Abdul Khader Mohammed, Bashair M Mussa, Nabil Sulaiman, Eman Abu-Gharbieh, Waseem El-Huneidi, Maha Saber Ayad
Investigating the Impact of IL6 on Insulin Secretion: Evidence from INS-1 Cells, Human Pancreatic Islets, and Serum Analysis. Cells 13 (8) (2024)
Amina Jamal Laham, Raafat El-Awady, Maha Saber Ayad, Ni Wang, Gang Yan, Julien Boudreault, Suhad Ali, Jean-Jacques Lebrun
Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs. NPJ precision oncology 8 (1) (2024)
Amina Jamal Laham, Raafat El-Awady, Maha Saber Ayad, Ni Wang, Gang Yan, Julien Boudreault, Suhad Ali, Jean-Jacques Lebrun
Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs. NPJ precision oncology 8 (1) (2024)
Amina Jamal Laham, Raafat El-Awady, Maha Saber Ayad, Ni Wang, Gang Yan, Julien Boudreault, Suhad Ali, Jean-Jacques Lebrun
Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs. NPJ precision oncology 8 (1) (2024)
Jalal Taneera, Anila Khalique, Abdul Khader Mohammed, Bashair M Mussa, Nabil Sulaiman, Eman Abu-Gharbieh, Waseem El-Huneidi, Maha Saber Ayad
Investigating the Impact of IL6 on Insulin Secretion: Evidence from INS-1 Cells, Human Pancreatic Islets, and Serum Analysis. Cells 13 (8) (2024)
Jalal Taneera, Anila Khalique, Abdul Khader Mohammed, Bashair M Mussa, Nabil Sulaiman, Eman Abu-Gharbieh, Waseem El-Huneidi, Maha Saber Ayad
Investigating the Impact of IL6 on Insulin Secretion: Evidence from INS-1 Cells, Human Pancreatic Islets, and Serum Analysis. Cells 13 (8) (2024)
Amina Jamal Laham, Raafat El-Awady, Maha Saber Ayad, Ni Wang, Gang Yan, Julien Boudreault, Suhad Ali, Jean-Jacques Lebrun
Author Correction: Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs. NPJ precision oncology 8 (1) (2024)
Jalal Taneera, Anila Khalique, Abdul Khader Mohammed, Bashair M Mussa, Nabil Sulaiman, Eman Abu-Gharbieh, Waseem El-Huneidi, Maha Saber Ayad
Investigating the Impact of IL6 on Insulin Secretion: Evidence from INS-1 Cells, Human Pancreatic Islets, and Serum Analysis. Cells 13 (8) (2024)
Amina Jamal Laham, Raafat El-Awady, Maha Saber Ayad, Ni Wang, Gang Yan, Julien Boudreault, Suhad Ali, Jean-Jacques Lebrun
Author Correction: Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs. NPJ precision oncology 8 (1) (2024)
Amina Jamal Laham, Raafat El-Awady, Maha Saber Ayad, Ni Wang, Gang Yan, Julien Boudreault, Suhad Ali, Jean-Jacques Lebrun
Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs. NPJ precision oncology 8 (1) (2024)
Amina Jamal Laham, Raafat El-Awady, Maha Saber Ayad, Ni Wang, Gang Yan, Julien Boudreault, Suhad Ali, Jean-Jacques Lebrun
Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs. NPJ precision oncology 8 (1) (2024)
Amina Jamal Laham, Raafat El-Awady, Maha Saber Ayad, Ni Wang, Gang Yan, Julien Boudreault, Suhad Ali, Jean-Jacques Lebrun
Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs. NPJ precision oncology 8 (1) (2024)
Charlotte Steenblock, Maha Saber Ayad, Stefan R Bornstein
International Roadshow: New Advances in Endocrinology and Metabolic Diseases. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 56 (4) (2024)
Noha Mousaad Elemam, Iman Mamdouh Talaat, Azzam A Maghazachi, Maha Saber Ayad
Liver Injury Associated with COVID-19 Infection: Pathogenesis, Histopathology, Prognosis, and Treatment. Journal of clinical medicine 12 (5) (2023)
Noha Mousaad Elemam, Iman Mamdouh Talaat, Azzam A Maghazachi, Maha Saber Ayad
Liver Injury Associated with COVID-19 Infection: Pathogenesis, Histopathology, Prognosis, and Treatment. Journal of clinical medicine 12 (5) (2023)
Noha Mousaad Elemam, Iman Mamdouh Talaat, Azzam A Maghazachi, Maha Saber Ayad
Liver Injury Associated with COVID-19 Infection: Pathogenesis, Histopathology, Prognosis, and Treatment. Journal of clinical medicine 12 (5) (2023)
Stefan R Bornstein, Diana Cozma, Margrit Kamel, Mawieh Hamad, Mohammad G Mohammad, Naveed A Khan, Maha Saber Ayad, Mohammad H Semreen, Charlotte Steenblock
Long-COVID, Metabolic and Endocrine Disease. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 54 (8) (2022)
Amina Jamal Laham, Raafat El-Awady, Jean-Jacques Lebrun, Maha Saber Ayad
A Bioinformatics Evaluation of the Role of Dual-Specificity Tyrosine-Regulated Kinases in Colorectal Cancer. Cancers 14 (8) (2022)
Amany Elsayed Ragab, Lamiaa A Al-Madboly, Ghada M Al-Ashmawy, Maha Saber Ayad, Mariam A Abo-Saif
Unravelling the In Vitro and In Vivo Anti- Helicobacter pylori Effect of Delphinidin-3- O -Glucoside Rich Extract from Pomegranate Exocarp: Enhancing Autophagy and Downregulating TNF-α and COX2. Antioxidants (Basel, Switzerland) 11 (9) (2022)
Khuloud Bajbouj, Rizwan Qaisar, Mohammed A Alshura, Zeinab Ibrahim, Mohamad Baraa Alebaji, Amenah W Al Ani, Hanadi M Janajrah, Mariah M Bilalaga, Abdelrahman I Omara, Rebal S Abou Assaleh, Maha Saber Ayad, Adel B Elmoselhi
Synergistic Anti-Angiogenic Effect of Combined VEGFR Kinase Inhibitors, Lenvatinib, and Regorafenib: A Therapeutic Potential for Breast Cancer. International journal of molecular sciences 23 (8) (2022)
Aminah Alchakee, Munazza Ahmed, Leen Eldohaji, Hamid Alhaj, Maha Saber Ayad
Pharmacogenomics in Psychiatry Practice: The Value and the Challenges. International journal of molecular sciences 23 (21) (2022)
Mohamed M El-Kady, Reham A Naggar, Maha Guimei, Iman Mamdouh Talaat, Olfat Gamil Shaker, Maha Saber Ayad
Early Renoprotective Effect of Ruxolitinib in a Rat Model of Diabetic Nephropathy. Pharmaceuticals (Basel, Switzerland) 14 (7) (2021)
Khuloud Bajbouj, Rakhee K Ramakrishnan, Maha Saber Ayad, Hany A Omar, Narjes Saheb Sharif-Askari, Jasmin Shafarin, Adel B Elmoselhi, Ahmed Ihmaid, Suhib AlHaj Ali, Abdulla Alalool, Reem Abdullah, Qutayba Hamid
PRMT5 Selective Inhibitor Enhances Therapeutic Efficacy of Cisplatin in Lung Cancer Cells. International journal of molecular sciences 22 (11) (2021)
Khuloud Bajbouj, Abeer Al-Ali, Rakhee K Ramakrishnan, Maha Saber Ayad, Qutayba Hamid
Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets. International journal of molecular sciences 22 (21) (2021)
Maha Saber Ayad, Sarah Hammoudeh, Eman Abu-Gharbieh, Rifat Akram Hamoudi, Hamadeh Tarazi, Taleb H Al-Tel, Qutayba Hamid
Current Status of Baricitinib as a Repurposed Therapy for COVID-19. Pharmaceuticals (Basel, Switzerland) 14 (7) (2021)
Shirin Hafezi, Maha Saber Ayad, Wael M Abdel-Rahman
Highlights on the Role of KRAS Mutations in Reshaping the Microenvironment of Pancreatic Adenocarcinoma. International journal of molecular sciences 22 (19) (2021)
Maha Guimei, Sana Alrouh, Maha Saber Ayad, Shirin A Hafezi, Arya Vinod, Surendra Rawat, Yazan Wardeh, Tala Mohamad Bakkour, Ahmed Taher El-Serafi
Inhibition of Yes-Associated Protein-1 (YAP1) Enhances the Response of Invasive Breast Cancer Cells to the Standard Therapy. Breast cancer (Dove Medical Press) 12 (2020)
Amina Jamal Laham, Maha Saber Ayad, Raafat El-Awady
DYRK1A: a down syndrome-related dual protein kinase with a versatile role in tumorigenesis. Cellular and molecular life sciences : CMLS 78 (2) (2020)
Maha Saber Ayad, Mohamed A Saleh, Eman Abu-Gharbieh
The Rationale for Potential Pharmacotherapy of COVID-19. Pharmaceuticals (Basel, Switzerland) 13 (5) (2020)
Maha Saber Ayad, Shaista Manzoor, Hadia M Radwan, Sarah Hammoudeh, Rahaf Wardeh, Ahmed Ashraf, Hussein Jabbar, Rifat Hamoudi
The FTO genetic variants are associated with dietary intake and body mass index amongst Emirati population. PloS one 14 (10) (2019)